Displaying 1 - 3 of 3 for Kidney
- ACH471-204 Investigational Drug Study (H-42881)
- The primary purpose of this Phase 2 clinical study is to evaluate the efficacy and safety of an investigational drug, to treat patients with either C3GN or dense deposit disease (DDD) based on renal biopsy.
- aHUS Registry (H-31731)
- The purpose of this study is to collect health and treatment information on patients previously diagnosed with atypical hemolytic uremic syndrome (aHUS).
- FIDELIO Study (H-41968)
- The purpose of this study is to find out more about an investigational medication for kidney disease.